Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2023-02-13 00:00:00 ET · period of report 2023-02-09 · accession 0001104659-23-019835 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-13 | 2023-02-09 | RYTM | Chien Jennifer | EVP, Head of North America | M - OptEx | — | +3,438 | 4,748 | +262% | — |
| D | 2023-02-13 | 2023-02-09 | RYTM | Chien Jennifer | EVP, Head of North America | S - Sale+OE | $27.66 | -1,192 | 3,556 | -25% | -$33.0K |
| D | 2023-02-13 | 2023-02-09 | RYTM | Chien Jennifer | EVP, Head of North America | M - OptEx | $0.00 | -3,438 | 10.3K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-09 | M | A | 3,438 | — | 4,748 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 2 | Common | Common Stock | 2023-02-09 | S | D | 1,192 | $27.66 | 3,556 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-02-09 | M | D | 3,438 | $0.00 | 10,312 | D | — · — to — | 3,438 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. |